Christopher P. Lowe Vincerx Pharma, Inc. (VINC) insider trading activity

Christopher P. Lowe is Director of Vincerx Pharma, Inc.. Currently has a direct ownership of 40,000 shares of VINC, which is worth approximately $10,800. The most recent transaction as insider was on Aug 25, 2022, when has been sold 11,600 shares (Common Stock) at a price of $1.65 per share, resulting in proceeds of $19,140. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K

0% 3M change

0% 12M change

Total Value Held $10,800

CHRISTOPHER P. LOWE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2022	BUY Open market or private purchase	$19,140 $1.65 p/Share	11,600 Added 22.48%	40,000 Common Stock
Aug 24 2022	BUY Open market or private purchase	$30,360 $1.65 p/Share	18,400 Added 39.32%	28,400 Common Stock
Jun 30 2021	BUY Open market or private purchase	$45,576 $12.66 p/Share	3,600 Added 26.47%	10,000 Common Stock
Jun 29 2021	BUY Open market or private purchase	$80,576 $12.59 p/Share	6,400 Added 50.0%	6,400 Common Stock

Also insider at

CRTX

Cortexyme, Inc. Healthcare

Interim CEO, COO & CFO

CPL